A qualitative study of seventeen Alberta healthcare providers reveals that barriers to colonoscopy after a positive fecal ...

Current US FDA-cleared stool-based colorectal cancer (CRC) molecular screening tests include fecal immunochemical tests (FIT) for occult blood detection; however, integration with nucleic acid-based ...

The SimpleScreen CRC blood test, developed by Freenome, will be sold exclusively by Abbott alongside its Cologuard Plus home ...

Researchers often use antibodies to detect specific molecules or biological markers because they are remarkably precise at ...

Biomarker testing in colorectal cancer (CRC) informs doctors about unique features of cancer that may influence its growth, spread, recurrence, and treatment response. Colorectal cancer (CRC), which ...

A 2023 study suggests that pain, changes in stool habits, rectal bleeding, and weight loss were the most common symptoms of colorectal cancer in adults under 50 years old. Almost all people with ...

Colorectal cancer has long been considered a disease of middle and later life, a diagnosis so strongly associated with older ...